WMG
BMY icon

WESCAP Management Group’s Bristol-Myers Squibb BMY Stock Holding History

WESCAP Management Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,923
Closed -$262K – 86
2021
Q2 		$262K Sell
3,923
-2,725
-41% -$178K 0.08% 82
2021
Q1 		$419K Sell
6,648
-2,309
-26% -$144K 0.12% 68
2020
Q4 		$555K Sell
8,957
-833
-9% -$51.2K 0.17% 64
2020
Q3 		$590K Sell
9,790
-2,053
-17% -$124K 0.2% 60
2020
Q2 		$696K Buy
+11,843
New +$708K 0.25% 60

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WESCAP Management Group's BMY Position: Q3 2021 in Review

WESCAP Management Group sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 3,923 shares — an estimated $262K sold.

WESCAP Management Group first reported a position in BMY in Q2 2020 and held it in 5 quarters. The position peaked at $696K in Q2 2020. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • WESCAP Management Group reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • WESCAP Management Group sold 3,923 Bristol-Myers Squibb shares in Q3 2021, an estimated $262K.
  • WESCAP Management Group first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 5 quarters.
  • WESCAP Management Group's Bristol-Myers Squibb position peaked at $696K in Q2 2020.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on WESCAP Management Group's 13F filing for Q3 2021, filed 12 Nov 2021.